Abstract
Loa loa is a long-lived parasite (up to 20 years of age) which is transmitted through the bites of deer flies (mainly Chrysops dimidiata and C. silacea). L. loa is endemic to Africa, from southeastern Benin in the west to southern Sudan in the east, and down south to Angola and possibly Zambia. Loiasis was first identified during the slave trade period. At that time, the disease was depicted by the spectacular passage of the adult worm under the bulbar conjunctiva of the eye (“eye worm”) and the transient episodes of subcutaneous migratory edema referred to as “Calabar swelling.” Since then, loiasis has also been associated with more severe symptoms such as cardiopathy (involving hypereosinophilia), nephropathy, and hormonal disturbance. Despite its endemic presence in Central Africa, with possibly tens of millions individuals concerned by the disease, loiasis has drawn little attention until the implementation of mass drug administration for lymphatic filariasis and onchocerciasis in the region. Indeed, post-therapeutic serious adverse events (SAEs) have occurred in individuals harboring high density of L. loa microfilariae. Solutions to prevent those SAEs are currently under evaluation in the field, but specific operational research on loiasis should nonetheless be encouraged.
Due to the intimate relationship among lymphatic filariasis, onchocercosis, mansonelliasis, and loiasis on diagnosis, distribution, and treatment, all four chapters need to be checked when solving problems related to any of them (CBM).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Akue JP, Hommel M, Devaney E (1997) High levels of parasite-specific IgG1 correlate with the amicrofilaremic state in Loa loa infection. J Infect Dis 175:158–163
Bakajika DK, Nigo MM, Lotsima JP et al (2014) Filarial antigenemia and Loa loa night blood microfilaremia in an area without bancroftian filariasis in the Democratic Republic of Congo. Am J Trop Med Hyg. doi:10.4269/ajtmh.14-0358
Bennuru S, Pion SD, Kamgno J et al (2014) Repurposed automated handheld counter as a point-of-care tool to identify individuals ‘at risk’ of serious post-ivermectin encephalopathy. PLoS Negl Trop Dis 8, e3180. doi:10.1371/journal.pntd.0003180
Bhedasgaonkar S, Baile RB, Nadkarni S et al (2011) Loa loa macrofilariasis in the eyelid: case report of the first periocular subcutaneous manifestation in India. J Parasit Dis 35:230–231. doi:10.1007/s12639-011-0043-6
Blum J, Wiestner A, Fuhr P, Hatz C (2001) Encephalopathy following Loa loa treatment with albendazole. Acta Trop 78:63–65
Boussinesq M (2006) Loiasis. Ann Trop Med Parasitol 100:715–731. doi:10.1179/136485906X112194
Boussinesq M (2012) Loiasis: new epidemiologic insights and proposed treatment strategy. J Travel Med 19:140–143
Boussinesq M, Gardon J (1997) Prevalences of Loa loa microfilaraemia throughout the area endemic for the infection. Ann Trop Med Parasitol 91:573–589
Boussinesq M, Gardon J, Gardon-Wendel N et al (2003) Clinical picture, epidemiology and outcome of Loa-associated serious adverse events related to mass ivermectin treatment of onchocerciasis in Cameroon. Filaria J 2(Suppl 1):S4. doi:10.1186/1475-2883-2-S1-S4
Burchard GD, Kern P (1987) Failure of high dose mebendazole as a microfilaricide in patients with loiasis. Trans R Soc Trop Med Hyg 81:420
Carme B, Boulesteix J, Boutes H et al (1991a) Five cases of encephalitis during treatment of loiasis with diethylcarbamazine. Am J Trop Med Hyg 44:684–690
Carme B, Ebkili B, Mbitsi A et al (1991b) Essai thérapeutique de l’ivermectine au cours de la loase à moyenne et forte microfilarémie. Ann Soc Belg Med Trop 71:47–50
Chesnais CB (2014) Recherches épidémiologiques appliquées à la lutte contre les filarioses en Afrique centrale. PhD thesis, Université de Montpellier, France
D’Ambrosio MV, Bakalar M, Bennuru S et al (2015) Rapid, point-of-care quantification of Loa loa microfilariae in human whole blood with a mobile phone microscope. Sci Transl Med 7:286. doi:10.1126/scitranslmed.aaa3480
Drame PM, Fink DL, Kamgno J et al (2014) Loop-mediated isothermal amplification for rapid and semiquantitative detection of Loa loa infection. J Clin Microbiol 52:2071–2077. doi:10.1128/JCM.00525-14
Duke BOL (1958) Studies on the biting habits of Chrysops. V. The biting-cycles and infection rates of C. silacea, C. dimidiata, C. langi and C. centurionis at canopy level in the rain-forest at Bombe, British Cameroons. Ann Trop Med Parasitol 52:24–35
Duke BOL (1963) Studies on the chemoprophylaxis of loiasis II. Observations on diethylcarbamazine citrate (Banocide) as a prophylactic in man. Trop Med Parasitol 57:82–96
Duke BOL (2004) Failed attempts at experimental transplantation and transmission of nocturnally-periodic simian Loa from monkey to man. Filaria J 3:5. doi:10.1186/1475-2883-3-5
Duke BO, Lewis DJ (1964) Studies on factors influencing the transmission of onchocerciasis. III. Observations on the effect of the peritrophic membrane in limiting the development of Onchocerca volvulus microfilariae in Simulium damnosum. Ann Trop Med Parasitol 58:83–88
Eveland LK, Yermakov V, Kenney M (1975) Loa loa infection without microfilaraemia. Trans R Soc Trop Med Hyg 69:354–355
Fain A (1978) Les problèmes actuels de la loase. Bull World Health Organ 56:155–167
Fain A, Maertens K (1973) Notes sur la ponte des microfilaires chez Loa loa et sur le degré de maturité des vers en migration. Bull Soc Pathol Exot 66:737–742
Fink DL, Kamgno J, Nutman TB (2011) Rapid molecular assays for specific detection and quantitation of Loa loa microfilaremia. PLoS Negl Trop Dis 5, e1299. doi:10.1371/journal.pntd.0001299.t003
Fobi G, Gardon J, Santiago M et al (2000) Ocular findings after ivermectin treatment of patients with high Loa loa microfilaremia. Ophthalmic Epidemiol 7:27–39
Garcia A, Abel L, Cot M et al (1999) Genetic epidemiology of host predisposition microfilaraemia in human loiasis. Trop Med Int Health 4:565–574
Gardon J, Gardon-Wendel N, Demanga-Ngangue et al (1997) Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet 350:18–22. doi:10.1016/S0140-6736(96)11094-1
Goussard B, Ivanoff B, Frost E et al (1984) Age of appearance of IgG, IgM, and IgE antibodies specific for Loa loa in Gabonese children. Microbiol Immunol 28:787–792
Kamgno J, Gardon J, Boussinesq M (2000) Essai de prévention des encé́phalopathies à Loa loa post-ivermectine par l’administration d’une faible dose initiale. Med Trop 60:275–277
Kamgno J, Djomo PN, Pion SD et al (2010) A controlled trial to assess the effect of quinine, chloroquine, amodiaquine, and artesunate on Loa loa microfilaremia. Am J Trop Med Hyg 82:379–385. doi:10.4269/ajtmh.2010.09-0573
Klion AD, Nutman TB (2011) Loiasis and Mansonella infections. In: Richard L (ed) Tropical infectious diseases: principles, pathogens, and practice, 2nd ed. Saunders and Elsevier Edinburgh, pp 1163–1175. Source: http://www.sciencedirect.com/science/article/pii/B9780702039355001427
Klion AD, Massougbodji A, Horton J et al (1993) Albendazole in human loiasis: results of a double-blind, placebo-controlled trial. J Infect Dis 168:202–206
Klion AD, Ottesen EA, Nutman TB (1994) Effectiveness of diethylcarbamazine in treating loiasis acquired by expatriate visitors to endemic regions: long-term follow-up. J Infect Dis 169:604–610
The Mectizan® Expert Committee, The Technical Consultative Committee (2004) Recommendations for the treatment of Onchocerciasis with Mectizan® in areas co-endemic for Onchocerciasis and Loiasis. http://www.who.int/apoc/publications/englishmectccloarecs-june04.pdf
Metzger WG, Mordmüller B (2014) Loa loa—does it deserve to be neglected? Lancet Infect Dis 14:353–357. doi:10.1016/S1473-3099(13)70263-9
Negesse YY, Lanoie LOL, Neafie RCR, Connor DHD (1985) Loiasis: “Calabar” swellings and involvement of deep organs. Am J Trop Med Hyg 34:537–546
Nutman TB, Miller KD, Mulligan M et al (1988) Diethylcarbamazine prophylaxis for human loiasis. Results of a double-blind study. N Engl J Med 319:752–756. doi:10.1056/NEJM198809223191204
Orihel TC, Eberhard ML (1985) Loa loa: development and course of patency in experimentally-infected primates. Trop Med Parasitol 36:215–224
Orihel TC, Moore PJ (1975) Loa loa: experimental infection in two species of African primates. Am J Trop Med Hyg 24:606–609
PATH (2014) New test will combat major cause of preventable blindness in Africa. http://www.path.org/news/press-room/703/. Accessed 26 Feb 2015
Pion SD, Montavon C, Chesnais CB et al (2014) Correlation between high Loa loa microfilaremia and levels of circulating filarial antigens used to detect Wuchereria bancrofti infection. ASTMH 63rd annual meeting, New Orleans, 2–6 Nov 2014
Pion SD, Chesnais CB, Bopda J et al (2015) The impact of mass drug administration with albendazole alone on lymphatic filariasis and soil-transmitted helminth infections: a community-based study in the Republic of Congo. Am J Trop Med Hyg 92:959–966
Richard-Lenoble D, Kombila M, Burnier I, Maganga ML (1985) Filarioses au Gabon: traitement par le mebendazole des filarioses à M. perstans et Loa loa. Bull Soc Pathol Exot 78:485–491
Richardson ET, Luo R, Fink DL et al (2012) Transient facial swellings in a patient with a remote African travel history. J Travel Med 19:183–185. doi:10.1111/j.1708-8305.2012.00612.x
Twum-Danso NAY, Meredith SEO (2003) Variation in incidence of serious adverse events after onchocerciasis treatment with ivermectin in areas of Cameroon co-endemic for loiasis. Trop Med Int Health 8:820–831. doi:10.1046/j.1365-3156.2003.01091.x
Van Bogaert L, Dubois A, Janssens PG et al (1955) Encephalitis in Loa loa filariasis. J Neurol Neurosurg Psychiatry 18:103–119
Van Hoegaerden M, Ivanoff B, Flocard F et al (1987) The use of mebendazole in the treatment of filariases due to Loa loa and Mansonella perstans. Ann Trop Med Parasitol 81:275–282
WHO (2010) Map of the estimated prevalence of eye worm history in Africa. WHO. http://www.who.int/apoc/raploa/en/
WHO (2012) Provisional strategies for interrupting lymphatic filariasis transmission in loiasis-endemic countries. Report on the meeting on lymphatic filariasis, malaria and integrated vector management. http://apps.who.int/iris/bitstream/10665/75139/3/WHO_HTM_NTD_PCT_2012.6_eng.pdf
Zouré HGM, Wanji S, Noma M et al (2011) The geographic distribution of Loa loa in Africa: results of large-scale implementation of the Rapid Assessment Procedure for Loiasis (RAPLOA). PLoS Negl Trop Dis 5, e1210. doi:10.1371/journal.pntd.0001210.t002
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Pion, S., Chesnais, C. (2017). Loiasis. In: Marcondes, C. (eds) Arthropod Borne Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-13884-8_27
Download citation
DOI: https://doi.org/10.1007/978-3-319-13884-8_27
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-13883-1
Online ISBN: 978-3-319-13884-8
eBook Packages: MedicineMedicine (R0)